Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Pharmacol., 29 August 2025

Sec. Ethnopharmacology

Volume 16 - 2025 | https://doi.org/10.3389/fphar.2025.1646824

This article is part of the Research TopicEnhancing Cancer Therapy: Integrating Plant-Derived Bioactives with Chemotherapy through Traditional Knowledge and Modern AdvancesView all 22 articles

Correction: Efficacy and safety of oral Chinese medicine combined with chemotherapy: a systematic review and network meta-analysis

This article is a correction to:

  1. Efficacy and safety of oral Chinese medicine combined with chemotherapy: A Systematic Review and Network Meta-analysis

    1. Read original article
Yuqi MaYuqi MaJia LiJia LiLiyun Liu &#x;Liyun Liu*†Tao Shen &#x;Tao Shen*†
  • School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China

A Correction on
Efficacy and safety of oral Chinese medicine combined with chemotherapy: a systematic review and network meta-analysis

by Ma Y, Li J, Liu L and Shen T (2025). Front. Pharmacol. 16:1579613. doi: 10.3389/fphar.2025.1579613

The figure graphics and captions for Figures 2, 3 were reversed in the published article. Figure 2 was incorrectly linked to the Figure 3 graphic, with the caption ‘Network graphs of outcomes. (A) Objective response rate. (B) TP therapy’, while Figure 3 was incorrectly linked to the Figure 2 graphic, with the caption ‘Risk of Bias Summary’. The in-text citations were correct. The graphic and caption order have now been corrected.

Figure 2
A risk assessment table evaluates studies from 2003 to 2023 across five categories: randomization process, deviations from intended interventions, missing outcome data, measurement of the outcome, and selection of the reported result. Each category is marked with symbols: green plus (low risk), yellow question mark (some concerns), or red minus (high risk). The overall assessment is indicated by the yellow exclamation mark for most cases, suggesting some concerns.

Figure 2. Risk of bias summary.

Figure 3
Two network diagrams labeled A and B. Diagram A shows a central node labeled

Figure 3. Network graphs of outcomes. (A) Objective response rate. (B) TP therapy.

The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: non-small-cell lung cancer, traditional Chinese medicine, network meta-analysis, oral Chinese medicine, safety

Citation: Ma Y, Li J, Liu L and Shen T (2025) Correction: Efficacy and safety of oral Chinese medicine combined with chemotherapy: a systematic review and network meta-analysis. Front. Pharmacol. 16:1646824. doi: 10.3389/fphar.2025.1646824

Received: 14 June 2025; Accepted: 01 August 2025;
Published: 29 August 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Ma, Li, Liu and Shen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Liyun Liu, bWF5dXFpMTk5OEBwcm90b24ubWU=; Tao Shen, bWF5dXFpMTk5ODA5MjZAb3V0bG9vay5jb20=

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.